Vasopressin V1a Antagonism Alleviates Diabetic Kidney Disease in Rats
Journal of the American Society of Nephrology · 2026-10 · 37 (10S)
DOI: 10.1681/asn.2026ecdm2zfa ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Society of Nephrology, 2026-10. Verfasst von Kerim Mutig und 10 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Mutig, K., Lebedeva, S. A., Bravyy, Y., Ilderbayev, O., Ayash, B., Amanova, Z., Kikimbayeva, A., Venediktov, A. A., Piavchenko, G. A., Mutash, S., & Uzbekov, D. (2026). Vasopressin V1a Antagonism Alleviates Diabetic Kidney Disease in Rats. Journal of the American Society of Nephrology, 37(10S). https://doi.org/10.1681/asn.2026ecdm2zfa
Vancouver
Mutig K, Lebedeva SA, Bravyy Y, Ilderbayev O, Ayash B, Amanova Z, et al. Vasopressin V1a Antagonism Alleviates Diabetic Kidney Disease in Rats. Journal of the American Society of Nephrology. 2026;37(10S). doi:10.1681/asn.2026ecdm2zfa
BibTeX
@article{Mutig2026,
author = {Mutig, Kerim and Lebedeva, Svetlana Anatolievna and Bravyy, Yan and Ilderbayev, Oralbek and Ayash, Batyrlan and Amanova, Zamira and Kikimbayeva, Aisulu and Venediktov, Artem A. and Piavchenko, Gennadii A. and Mutash, Saltanat and Uzbekov, Darkhan},
title = {Vasopressin V1a Antagonism Alleviates Diabetic Kidney Disease in Rats},
journal = {Journal of the American Society of Nephrology},
year = {2026},
volume = {37},
number = {10S},
doi = {10.1681/asn.2026ecdm2zfa}
}
EUVIMED